Coming Soon

Interested in sampling? Be the first to hear about these new products, register your interest today.

Register your interest to be the first to hear about our new products:

New Antibodies and Antigens - Coming Soon

In Development

“This is an exciting new era for BBI Solutions, having internal control over new antibody development projects to ensure we are bringing highly characterised antibodies to market ready for use by IVD assay developers.”

Dr. James Steggles, Commercial Manager for Antibodies, BBI Solutions.

In response to market demands and customer requests our new product development team are currently developing antibodies and antigens for:


  • Zika (coming soon)
  • Dengue

Having a combined team of antibody and assay development specialists allows BBI to select antibodies from a large pool of candidates screened with IVD customer applications in mind. All antibodies developed by BBI Solutions are produced in-house under cGMP conditions for long-term security of supply.


Developed under ISO 13485 conditions by our experienced team of experts, ensures high quality antigens that meet market specifications and a trusted secure supply.

  • CEA
  • FABP (Heart)
  • HE4
  • HIV-1 p24
  • Human TPO
  • S100B
  • Troponin I, Troponin T, Troponin C
Copyright © 2019 BBI Solutions. All rights reserved. Designed trademarks and brands are the property of their respective owners. BBIUS